dpp 4 inhibitor and glp 1 agonist Specific actions of GLP-1 receptor agonists DPP4 inhibitors for the treatment of pancreatic β-cell impairments in type 2 diabetes Cardiovascular effects of the DPP-4
Description
[DOI] [PubMed] [Google Scholar] 73.Vertongen P, et al
Further research is warranted to explore long-term outcomes and optimize treatment protocols for this patient population
Information supplied to their GLP-1 patients TGA is recommending that patients only fill their prescription for GLP-1 therapies if their doctor confirms that this is still the best treatment option for the specific patient
Although 16 of the 30 amino acids in its N-terminus are identical to human GLP-1 (36) amide, exendin-4 is not the lizard homolog of GLP-1
Albiglutide does not prolong QTc interval in healthy subjects: A thorough ECG study
